Webb9 dec. 2024 · You cannot join this trial if any of these apply. You: have cancer in both breasts have very small areas of calcium (microcalcification) in your breast which has shown on your mammogram that is outside the cancer have cancer that has receptors for HER2 have cancer that is in the lining of the lobules of the breast (invasive lobular … Webb14 apr. 2024 · Psilocybin-assisted therapy could help patients with cancer and major depression disorder, according to new data from an open-label Phase II trial published in JAMA Oncology.. Sunstone Therapies reported results from a 30-patient Phase II trial suggesting psilocybin and group therapy could lead to sustained reductions of …
Pragmatica-Lung Study opens for patient enrollment - NCI
Webb10 juni 2024 · Memorial Sloan Kettering Cancer Center in New York conducted a small trial of just 14 people with rectal cancer. After completing the trial with an experimental … Webb5 juni 2024 · Mismatch repair–deficient, locally advanced rectal cancer was highly sensitive to single-agent PD-1 blockade. Longer follow-up is needed to assess the … how do you calculate breakeven revenue
Durvalumab Recruiting Phase 2 Trials for Non Small Cell Lung Cancer …
Webb12 apr. 2024 · Chinese Clinical Trial Registry ( www.chictr.org.cn ): ChiCTR2100046237. Registered on 12 May 2024. Effects of prebiotic supplement on gut microbiota, drug bioavailability, and adverse effects in patients with colorectal cancer at different primary tumor locations receiving chemotherapy: ... WebbSponsors: Lead Sponsor: Sun Yat-sen University Source: Sun Yat-sen University Brief Summary: A multicenter, single-arm, open study to evaluate the safety and efficacy of Serplulimab in combination with bevacizumab and first-line chemotherapy in driver negative non-squamous NSCLC patients with brain metastases Webb3 feb. 2024 · Brief Summary: This Randomized Phase 3 Open-label Study will Evaluate the Efficacy of Zimberelimab (AB122) Monotherapy Compared to Standard Chemotherapy or Zimberelimab Combined with AB154 in Front-Line, PD-L1-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer. Study Design Go to pho murfreesboro tn